Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which High-Tech camera is better at spotting skin cancer?

NCT ID NCT07740642

Not yet recruiting Knowledge-focused Sponsor: University Hospital, Basel, Switzerland Source: ClinicalTrials.gov ↗

First seen Jul 31, 2026 · Last updated Aug 04, 2026 · Updated 2 times

Summary

This study compares two total body photography systems used to screen for melanoma, a serious skin cancer. One system, Deviskan, takes automated images with non-contact dermoscopy, while the other, Vectra WB360, uses 3D photography with manual dermoscopy. Researchers will ask 60 people at high risk for melanoma about their sense of safety with each system, and also measure how long each examination takes. The goal is to understand which system patients and dermatologists prefer and which is more efficient in a real-world setting.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Two total body skin imaging systems: Deviskan (automated non-contact dermoscopy) and Vectra WB360 (3D photography with manual dermoscopy)
What this could lead to
If one system proves more efficient and preferred, it could become a standard tool for melanoma screening, potentially improving early detection.
What could go wrong
This is a small usability study, not a test of diagnostic accuracy. Preferences and time savings may not translate to better health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MELANOMA (SKIN CANCER) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

melanoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MELANOMA (SKIN CANCER)

Contacts and locations

Locations

  • University Hospital Basel

    Basel, Canton of Basel-City, 4055, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.